Jeffrey Simmons, President CEO of Elanco Animal Health (ELAN), discusses the company’s latest quarterly report. “We have seen an amazing start to the year,” he says. “Growth, innovation, cash is our value proposition to investors,” he adds, citing 8 straight quarters of growth. “We have 5 major innovations in major markets,” including in the $6B flea and tick prevention market and in dermatology, the “number 1 reason” for dog vet appointments. Jeffrey also discusses their deleveraging strategies, including selling their aqua business and paying down debt.